Scilight Press

Author Information

Received: 17 Mar 2025 | Revised: 16 Apr 2025 | Accepted: 06 May 2025 | Published: 21 May 2025

Abstract

Keywords

silica | silicosis | rheumatoid arthritis | scleroderma | systemic lupus erythematosus | dermatomyositis | sjögren syndrome | vasculitis

References 

• 1.
  Bramwell, B. Diffuse scleroderma: Its frequency, its occurrence in stonemasons, its treatment by fibrinolysin, elevation of temperature due to fibrinolysin injections. Edinb. Med. J. 1914, 12, 387–401.
• 2.
  Ronsmans, S.; Blanc, P.D. Colinet-Caplan Syndrome: History of an Outbreak of Autoimmune Disease in Scouring Powder Workers. Ann. Intern. Med. 2023, 176, 260–265.
• 3.
  Caplan, A. Certain unusual radiological appearances in the chest of coal miners suffering from rheumatoid arthritis. Thorax 1953, 8, 29–37.
• 4.
  Miall, W.E.; Caplan, A.; Cochrane, A.L.; et al. An epidemiological study of rheumatoid arthritis associated with characteristic chest x-ray appearances in coal workers. Br. Med. J. 1953, 2, 1231–1236.
• 5.
  Nemakalaya, D.R.; Ramphul, K. Caplan Syndrome; StatePearls Publishing: Treasure Island, FL, USA, 2019.
• 6.
  Koeger, A.C.; Lang, T.; Alcaix, D.; et al. Silica-associated connective tissue disease. A study of 24 cases. Medicine 1995, 74, 221–237.
• 7.
  Miller, F.W.; Alfredsson, L.; Costenbader, K.H.; et al. Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J. Autoimmun. 2012, 39, 259–271.
• 8.
  Parks, C.G.; Conrad, K.; Cooper, G.S. Occupational exposure to crystalline silica and autoimmune disease. Environ. Health Perspect. 1999, 107 (Suppl. 5), 793–802.
• 9.
  Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71.
• 10.
  The, U.S. National Institutes of Health. Study Quality Assessment Tools. Available online: https://www. nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed on 26 February 2025).
• 11.
  King, T.E.; Kim, E.J.; Kinder, B.W. Connective Tissue Diseases. In Interstitial Lung Disease, 5 ed.; People’s Medical Publishing House: Shelton, CT, USA, 2011; pp 89–764.
• 12.
  Juge, P.A.; Borie, R.; Kannengiesser, C.; et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur. Respir. J. 2017, 49, 1602314.
• 13.
  Rego-Pérez, I.; Fernández-Moreno, M.; Blanco, F.J. Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis. Curr. Genom. 2008, 9, 381–393.
• 14.
  Alaya, Z.; Braham, M.; Aissa, S.; et al. A case of Caplan syndrome in a recently diagnosed patient with silicosis: A case report. Radiol. Case Rep. 2018, 13, 663–666.
• 15.
  Rosenman, K.D.; Zhu, Z. Pneumoconiosis and associated medical conditions. Am. J. Ind. Med. 1995, 27, 107–113.
• 16.
  Blanc, P.D.; Trupin, L.; Yelin, E.H.; et al. Assessment of Risk of Rheumatoid Arthritis Among Underground Hard Rock and Other Mining Industry Workers in Colorado, New Mexico, and Utah. JAMA Netw. Open 2022, 5, e2236738.
• 17.
  Schmajuk, G.; Trupin, L.; Yelin, E.H.; et al. Dusty trades and associated rheumatoid arthritis in a population-based study in the coal mining counties of Appalachia. Occup. Environ. Med. 2022, 79, 308–314.
• 18.
  Schmajuk, G.; Trupin, L.; Yelin, E.; et al. Prevalence of Arthritis and Rheumatoid Arthritis in Coal Mining Counties of the United States. Arthritis Care Res. 2019, 7, 1209–1215.
• 19.
  Makol, A.; Reilly, M.J.; Rosenman, K.D. Prevalence of connective tissue disease in silicosis (1985–2006)- a report from the state of Michigan surveillance system for silicosis. Am. J. Ind. Med. 2011, 54, 255–262.
• 20.
  Rosenman, K.D.; Moore-Fuller, M.; Reilly, M.J. Connective tissue disease and silicosis. Am. J. Ind. Med. 1999, 35, 375–381.
• 21.
  Miall, W.E. Rheumatoid arthritis in males: An epidemiological study of a Welsh mining community. Ann. Rheum. Dis. 1955, 14, 150–158.
• 22.
  Lee, S.; Ma, X.; Lee, W. Association between exposure to external airborne agents and autoimmune disease. Ecotoxicol. Environ. Saf. 2023, 263, 115334.
• 23.
  Min, Y.S.; Kim, M.G.; Ahn, Y.S. Rheumatoid Arthritis in Silica-Exposed Workers. Int. J. Environ. Res. Public Health 2021, 18, 12776.
• 24.
  Boudigaard, S.H.; Schlünssen, V.; Vestergaard, J.M.; et al. Occupational exposure to respirable crystalline silica and risk of autoimmune rheumatic diseases: A nationwide cohort study. Int. J. Epidemiol. 2021, 50, 1213–1226.
• 25.
  Vihlborg, P.; Bryngelsson, I.L.; Andersson, L.; et al. Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: A retrospective cohort study. BMJ Open 2017, 7, e016839.
• 26.
  Blanc, P.D.; Järvholm, B.; Torén, K. Prospective risk of rheumatologic disease associated with occupational exposure in a cohort of male construction workers. Am. J. Med. 2015, 128, 1094–1101.
• 27.
  Li, X.; Sundquist, J.; Sundquist, K. Socioeconomic and occupational risk factors for rheumatoid arthritis: A nationwide study based on hospitalizations in Sweden. J. Rheumatol. 2008, 35, 986–991.
• 28.
  Steenland, K.; Sanderson, W.; Calvert, G.M. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 2001, 12, 405–412.
• 29.
  Brown, L.M.; Gridley, G.; Olsen, J.H.; et al. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J. Occup. Environ. Med. 1997, 39, 633–638.
• 30.
  Steenland, K.; Brown, D. Mortality study of gold miners exposed to silica and nonasbestiform amphibole minerals: An update with 14 more years of follow-up. Am. J. Ind. Med. 1995, 27, 217–229.
• 31.
  Lundberg, I.; Alfredsson, L.; Plato, N.; et al. Occupation, occupational exposure to chemicals and rheumatological disease. A register-based cohort study. Scand. J. Rheumatol. 1994, 23, 305–310.
• 32.
  Klockars, M.; Koskela, R.S.; Järvine, E.; et al. Silica exposure and rheumatoid arthritis: A follow up study of granite workers 1940–1981. Br. Med. J. 1987, 294, 997–1000.
• 33.
  Sigaux, J.; Cavalin, C.; Lescoat, A.; et al. Are cleaning activities a source of exposure to crystalline silica in women with rheumatoid arthritis? A case-control study. RMD Open 2023, 9, e003205.
• 34.
  Cavalin, C.; Lescoat, A.; Sigaux, J.; et al. Crystalline silica exposure in patients with rheumatoid arthritis and systemic sclerosis: A nationwide cross-sectional survey. Rheumatology 2023, 62, 2707–2715.
• 35.
  Wrangel, O.; Graff, P.; Bryngelsson, I.L.; et al. Silica Dust Exposure Increases Ri.sk for Rheumatoid Arthritis: A Swedish National Registry Case-Control Study. J. Occup. Environ. Med. 2021, 63, 951–955.
• 36.
  Ilar, A.; Alfredsson, L.; Wiebert, P.; et al. Occupation and Risk of Developing Rheumatoid Arthritis: Results from a Population-Based Case-Control Study. Arthritis Care Res. 2018, 70, 499–509.
• 37.
  Yahya, A.; Bengtsson, C.; Larsson, P.; et al. Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: Evidence from the Malaysian MyEIRA case-control study. Mod. Rheumatol. 2014, 24, 271–274.
• 38.
  Stolt, P.; Yahya, A.; Bengtsson, C.; et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69, 1072–1076.
• 39.
  Cooper, G.S.; Wither, J.; Bernatsky, S.; et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: Silica, sunlight, solvents. Rheumatology 2010, 49, 2172–2180.
• 40.
  Gold, L.S.; Ward, M.H.; Dosemeci, M.; et al. Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum. 2007, 56, 3189–3201.
• 41.
  Finckh, A.; Cooper, G.S.; Chibnik, L.B.; et al. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum. 2006, 54, 3648–3654.
• 42.
  Stolt, P.; Källberg, H.; Lundberg, I.; et al. Silica exposure is associated with increased risk of developing rheumatoid arthritis: Results from the Swedish EIRA study. Ann. Rheum. Dis. 2005, 64, 582–586.
• 43.
  Calvert, G.M.; Rice, F.L.; Boiano, J.M.; et al. Occupational silica exposure and risk of various diseases: An analysis using death certificates from 27 states of the United States. Occup. Environ. Med. 2003, 60, 122–129.
• 44.
  McKenzie, J.E.; Brennan, S.E.; Ryan, R.E.; et al. Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In Cochrane Handbook for Systematic Reviews of Interventions; Version 6.5; Cochrane Collaboration: London, UK,2011; Available online: https://training.cochrane.org/handbook/current (accessed on 25 April 2025).
• 45.
  Sluis-Cremer, G.K.; Hessel, P.A.; Hnizdo, E.; et al. Relationship between silicosis and rheumatoid arthritis. Thorax 1986, 41, 596–601.
• 46.
  Turner, S.; Cherry, N. Rheumatoid arthritis in workers exposed to silica in the pottery industry. Occup. Environ. Med. 2000, 57, 443–447.
• 47.
  Agarwal, S.K. The Genetics of Systemic Sclerosis. Discov. Med. 2010, 10, 134–143.
• 48.
  Erasmus, L.D. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S. Afr. J. Lab Clin. Med. 1957, 3, 209–231.
• 49.
  Rustin, M.H.; Bull, H.A.; Ziegler, V.; et al. Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br. J. Dermatol. 1990, 123, 725–734.
• 50.
  Devulder, B.; Plouvier, B.; Martin, J.C.; et al. The scleroderma-silicosis association or Erasmus’ syndrome. Nouv. Presse Med. 1977, 6, 2877–2879. (In French)
• 51.
  Yang, Y.; Wei, P.; Guo, X.J.; et al. Impact of age and autoantibody status on the gene expression of scleroderma fibroblasts in response to silica stimulation. Eur. J. Inflamm. 2013, 11, 631–639.
• 52.
  Baur, X.; Rihs, H.P.; Altmeyer, P.; et al. Systemic sclerosis in German uranium miners under special consideration of autoantibody subsets and HLA class II alleles. Respiration 1996, 63, 368–375.
• 53.
  Turner, M.T.; Samuel, S.R.; Silverstone, E.J.; et al. Silica Exposure and Connective Tissue Disease: An Underrecognized Association in Three Australian Artificial Stone Workers. Am. J. Respir. Crit. Care Med. 2020, 201, 378–380.
• 54.
  Freire, M.; Sopeña, B.; González-Quintela, A.; et al. Autoimmune Diseases Study Group (GEAS). Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis. Autoimmun. Rev. 2024, 23, 103542.
• 55.
  Galli, G.; De Pous-Gerardin, C.; Hanguehard, R.; et al. Occupational quantitative exposure to crystalline silica, solvents and pesticides and risk of clinical forms of systemic sclerosis. Rheumatology 2024, 63, 3397–3406.
• 56.
  Aguila, L.A.; da Silva, H.C.; Medeiros-Ribeiro, A.C.; et al. Is exposure to environmental factors associated with a characteristic clinical and laboratory profile in systemic sclerosis? A retrospective analysis. Rheumatol. Int. 2021, 41, 1143–1150.
• 57.
  Patel, S.; Morrisroe, K.; Proudman, S.; et al. Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology 2020, 59, 3900–3905.
• 58.
  Ballerie, A.; Cavalin, C.; Lederlin, M.; et al. Association of silica exposure with chest HRCT and clinical characteristics in systemic sclerosis. Semin. Arthritis Rheum. 2020, 50, 949–956.
• 59.
  Rocha, L.F.; Luppino Assad, A.P.; Marangoni, R.G.; et al. Systemic sclerosis and silica exposure: A rare association in a large Brazilian cohort. Rheumatol. Int. 2016, 36, 697–702.
• 60.
  Marie, I.; Menard, J.F.; Duval-Modeste, A.B.; et al. Association of occupational exposure with features of systemic sclerosis. J. Am. Acad. Dermatol. 2015, 72, 456–464.
• 61.
  Granel, B.; Zemour, F.; Lehucher-Michel, M.P.; et al. Occupational exposure and systemic sclerosis. Literature review and result of a self-reported questionnaire. Rev. Med. Intern. 2008, 29, 891–900. (In French)
• 62.
  Magnant, J.; de Monte, M.; Guilmot, J.L.; et al. Relationship between occupational risk factors and severity markers of systemic sclerosis. J. Rheumatol. 2005, 32, 1713–1718.
• 63.
  Conrad, K.; Stahnke, G.; Liedvogel, B.; et al. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J. Rheumatol. 1995, 22, 1286–1294.
• 64.
  Sanchez-Roman, J.; Wichmann, I.; Salaberri, J.; et al. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann. Rheum. Dis. 1993, 52, 534–538.
• 65.
  Cowie, R.L.; Dansey, R.D. Features of systemic sclerosis (scleroderma) in South African goldminers. S. Afr. Med. J. 1990, 77, 400–402.
• 66.
  Haustein, U.F.; Ziegler, V.; Herrmann, K.; et al. Silica-induced scleroderma. J. Am. Acad. Dermatol. 1990, 22, 444–448.
• 67.
  Cowie, R.L. Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest 1987, 92, 260–262.
• 68.
  Marie, I.; Gehanno, J.F.; Bubenheim, M.; et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun. Rev. 2014, 13, 151–156.
• 69.
  Bovenzi, M.; Barbone, F.; Pisa, F.E.; et al. A case-control study of occupational exposures and systemic sclerosis. Int. Arch. Occup. Environ. Health 2004, 77, 10–16.
• 70.
  Maître, A.; Hours, M.; Bonneterre, V.; et al. Systemic sclerosis and occupational risk factors: Role of solvents and cleaning products. J. Rheumatol. 2004, 31, 2395–2401.
• 71.
  Diot, E.; Lesire, V.; Guilmot, J.L.; et al. Systemic sclerosis and occupational risk factors: A case-control study. Occup. Environ. Med. 2002, 59, 545–549.
• 72.
  Thompson, A.E.; Pope, J.E. Increased prevalence of scleroderma in southwestern Ontario: A cluster analysis. J. Rheumatol. 2002, 29, 1867–1873.
• 73.
  Bovenzi, M.; Barbone, F.; Pisa, F.E.; et al. Scleroderma and occupational exposure to hand-transmitted vibration. Int. Arch. Occup. Environ. Health 2001, 74, 579–582.
• 74.
  Englert, H.; Small-McMahon, J.; Davis, K.; et al. Male systemic sclerosis and occupational silica exposure—A population-based study. Aust. N. Z. J. Med. 2000, 30, 215–220.
• 75.
  Burns, C.J.; Laing, T.J.; Gillespie, B.W.; et al. The epidemiology of scleroderma among women: Assessment of risk from exposure to silicone and silica. J. Rheumatol. 1996, 23, 1904–1911.
• 76.
  Bovenzi, M.; Barbone, F.; Betta, A.; et al. Scleroderma and occupational exposure. Scand. J. Work Environ. Health 1995, 21, 289–292.
• 77.
  Silman, A.J.; Jones, S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann. Rheum. Dis. 1992, 51, 1322–1324.
• 78.
  Sluis-Cremer, G.K.; Hessel, P.A.; Nizdo, E.H.; et al. Silica, silicosis, and progressive systemic sclerosis. Br. J. Ind. Med. 1985, 42, 838–843.
• 79.
  Walsh, S.J. Effects of non-mining occupational silica exposure on proportional mortality from silicosis and systemic sclerosis. J. Rheumatol. 1999, 26, 2179–2185.
• 80.
  Leffers, H.C.B.; Lange, T.; Collins, C.; et al. The study of interactions between genome and exposome in the development of systemic lupus erythematosus. Autoimmun. Rev. 2019, 18, 382–392.
• 81.
  Conrad, K.; Mehlhorn, J.; Lüthke, K.; et al. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: Clinical and serological characteristics. Lupus 1996, 5, 62–69.
• 82.
  Li, X.; Sundquist, J.; Sundquist, K.; et al. Occupational risk factors for systemic lupus erythematosus: A nationwide study based on hospitalizations in Sweden. J. Rheumatol. 2012, 39, 743–751.
• 83.
  Parks, C.G.; Cooper, G.S.; Nylander-French, L.A.; et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the southeastern United States. Arthritis Rheum. 2002, 46, 1840–1850.
• 84.
  Centers for Disease Control and Prevention (CDC). Silicosis in dental laboratory technicians—Five states, 1994–2000. MMWR 2004, 53, 195–197.
• 85.
  Morotti, A.; Sollaku, I.; Catalani, S.; et al. Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus. Rheumatology 2021, 60, 81–91.
• 86.
  Mitchell, D.N.; Wells, A.; Spiro, S.G. Sarcoidosis; CRC Press: Boca Raton, FL, USA, 2012.
• 87.
  Dhagat, P.K.; Singh, S.; Jain, M.; et al. Thoracic Sarcoidosis: Imaging with High Resolution Computed Tomography. J. Clin. Diagn. Res. 2017, 11, TC15–TC18.
• 88.
  Tanabe, T.; Yamaguchi, N.; Okuda, M.; et al. Immune System Reaction against Environmental Pollutants. Nippon. Eiseigaku Zasshi 2015, 70, 115–119. (In Japanese)
• 89.
  Raanan, R.; Zack, O.; Ruben, M.; et al. Occupational Silica Exposure and Dose-Response for Related Disorders-Silicosis, Pulmonary TB, AIDs and Renal Diseases: Results of a 15-Year Israeli Surveillance. Int. J. Environ. Res. Public Health 2022, 19, 15010.
• 90.
  Falchi, M.; Paoletti, L.; Mariotta, S.; et al. Non-fibrous inorganic particles in bronchoalveolar lavage fluid of pottery workers. Occup. Environ. Med. 1996, 53, 762–766.
• 91.
  Iversen, I.B.; Vestergaard, J.M.; Ohlander, J.; et al. Occupational exposure to respirable crystalline silica and incident idiopathic interstitial pneumonias and pulmonary sarcoidosis: A national prospective follow-up study. Occup. Environ. Med. 2024, 81, 279–286.
• 92.
  Jonsson, E.; Järvholm, B.; Andersson, M. Silica dust and sarcoidosis in Swedish construction workers. Occup. Med. 2019, 69, 482–486.
• 93.
  Izbicki, G.; Chavko, R.; Banauch, G.I.; et al. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 2007, 131, 1414–1423.
• 94.
  Graff, P.; Larsson, J.; Bryngelsson, I.L.; et al. Sarcoidosis and silica dust exposure among men in Sweden: A case-control study. BMJ Open 2020, 10, e038926.
• 95.
  Beijer, E.; Meek, B.; Bossuyt, X.; et al. Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients. Respir. Res. 2020, 21, 141.
• 96.
  Rafnsson, V.; Ingimarsson, O.; Hjalmarsson, I.; et al. Association between exposure to crystalline silica and risk of sarcoidosis. Occup. Environ. Med. 1998, 55, 657–660.
• 97.
  Bodokh, I.; Brun, P.; Mayaffre, C.; et al. Cutaneous sarcoidosis secondary to inhalation of wall insulating material particles. Ann. Dermatol. Venereol. 1998, 125, 182–184. (In French)
• 98.
  Chaigne, B.; Lasfargues, G.; Marie, I.; et al. Primary Sjögren’s syndrome and occupational risk factors: A case-control study. J. Autoimmun. 2015, 60, 80–85.
• 99.
  Knight, A.; Sandin, S.; Askling, J. Occupational risk factors for Wegener’s granulomatosis: A case-control study. Ann. Rheum. Dis. 2010, 69, 737–740.
• 100.
  Nuyts, G.D.; Van Vlem, E.; De Vos, A.; et al. Wegener granulomatosis is associated to exposure to silicon compounds: A case-control study. Nephrol. Dial. Transplant. 1995, 10, 1162–1165.
• 101.
  Stamp, L.K.; Chapman, P.T.; Francis, J.; et al. Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand. Arthritis Res. Ther. 2015, 17, 333.
• 102.
  Bartůnková, J.; Pelclová, D.; Fenclová, Z; et al. Exposure to silica and risk of ANCA-associated vasculitis. Am. J. Ind. Med. 2006, 49, 569–576.
• 103.
  Hogan, S.L.; Cooper, G.S.; Savitz, D.A.; et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: A population-based, case-control study. Clin. J. Am. Soc. Nephrol. 2007, 2, 290–299.
• 104.
  Beaudreuil, S.; Lasfargues, G.; Lauériere, L.; et al. Occupational exposure in ANCA-positive patients: A case-control study. Kidney Int. 2005, 67, 1961–1966.
• 105.
  Lane, S.E.; Watts, R.A.; Bentham, G.; et al. Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum. 2003, 48, 814–823.
• 106.
  Kronzer, V.L.; Kimbrough, B.A.; Crowson, C.S.; et al. Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study. Arthritis Care Res. 2023, 75, 348–355.
• 107.
  Matsuoka, Y.; Tomita, M.; Yoshino, I.; et al. Relationship between autoimmune diseases and pneumoconiosis. Sangyo Igaku 1992, 34, 421–431. (In Japanese)
• 108.
  Maeda, M.; Nishimura, Y.; Kumagai, N.; et al. Dysregulation of the immune system caused by silica and asbestos. J. Immunotoxicol. 2010, 7, 268–278.
• 109.
  Pernis, B. Silica and the immune system. Acta Biomed. 2005, 76 (Suppl. 2), 38–44.
• 110.
  Takata-Tomokuni, A.; Ueki, A.; Shiwa, M.; et al. Detection, epitope-mapping and function of anti-Fasautoantibody in patients with silicosis. Immunology 2005, 116, 21–29.
• 111.
  Sakaguchi, S. Naturally-arising Foxp3-expressing CD25+CD4+ regulatory T-cells in immunological tolerance to self and non-self. Nat. Immunol. 2005, 6, 345–352.
• 112.
  Wu, P.; Miura, Y.; Hyodoh, F.; et al. Reduced function of CD4+25+ regulatory T-cell fraction in silicosis patients. Int. J. Immunopathol. Pharmacol. 2006, 19, 357–368.
• 113.
  Subra, J.F.; Renier, G.; Reboul, P.; et al. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin. Exp. Immunol. 2001, 126, 540–544.
• 114.
  Brilland, B.; Beauvillain, C.; Mazurkiewicz, G.; et al. T Cell Dysregulation in Non-silicotic Silica Exposed Workers: A Step Toward Immune Tolerance Breakdown. Front. Immunol. 2019, 10, 2743.
• 115.
  Rocha, M.C.; Santos, L.M.; Bagatin, E.; et al. Genetic polymorphisms and surface expression of CTLA-4 and PD-1 on T cells of silica-exposed workers. Int. J. Hyg. Environ. Health 2012, 215, 562–569.
• 116.
  Rocha-Parise, M.; Santos, L.M.; Damoiseaux, J.G.; et al. Lymphocyte activation in silica-exposed workers. Int. J. Hyg. Environ. Health. 2014, 217, 586–591.
• 117.
  Carlsten, C.; de Roos, A.J.; Kaufman, J.D.; et al. Cell markers, cytokines, and immune parameters in cement mason apprentices. Arthritis Rheum. 2007, 57, 147–153.
• 118.
  Stratta, P.; Messuerotti, A.; Canavese, C.; et al. The role of metals in autoimmune vasculitis: Epidemiological and pathogenic study. Sci. Total Environ. 2001, 270, 179–190.
• 119.
  Cooper, G.S.; Parks, C.G.; Schur, P.S.; et al. Occupational and environmental associations with antinuclear antibodies in a general population sample. J. Toxicol. Environ. Health A 2006, 69, 2063–2069.
• 120.
  Conrad, K.; Levy, Y.; Blank, M.; et al. The pathogenic 16/6 idiotype in patients with silica-associated systemic lupus erythematosus (SLE) and uranium miners with increased risk for development of SLE. J. Rheumatol. 1998, 25, 660–666.
• 121.
  Wichmann, I.; Sanchez-Roman, J.; Morales, J.; et al. Antimyeloperoxidase antibodies in individuals with occupational exposure to silica. Ann. Rheum. Dis. 1996, 55, 205–207.
• 122.
  Tomic, D.; Hoy, R.F.; Sin, J.; et al. Autoimmune diseases, autoantibody status and silicosis in a cohort of 1238 workers from the artificial stone benchtop industry. Occup. Environ. Med. 2024, 81, 388–394.
• 123.
  Raptopoulou, A.; Sidiropoulos, P.; Katsouraki, M.; et al. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: Evolving concepts”. Crit. Rev. Clin. Lab Sci. 2007, 44, 339–363.
• 124.
  Murphy, D.; Bellis, K.; Hutchinson, D. Vapour, gas, dust and fume occupational exposures in male patients with rheumatoid arthritis resident in Cornwall (UK) and their association with rheumatoid factor and anti-cyclic protein antibodies: A retrospective clinical study. BMJ Open 2018, 8, e021754.
• 125.
  Aminian, O.; Sharifian, S.A.; Mehrdad, R.; et al. Antinuclear antibody and rheumatoid factor in silica-exposed workers. Arh. Hig. Rada Toksikol. 2009, 60, 185–190.
• 126.
  Aksu, N.; Samadi, A.; Yalçınkaya, A.; et al. Evaluation of oxysterol levels of patients with silicosis by LC-MS/MS method. Mol. Cell Biochem. 2020, 467, 117–125.
• 127.
  Morotti, A.; Sollaku, I.; Franceschini, F.; et al. Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis. Clin. Rev. Allergy Immunol. 2022, 62, 333–345.
• 128.
  Rubio-Rivas, M.; Moreno, R.; Corbella, X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin. Rheumatol. 2017, 36, 569–582.
• 129.
  Gómez-Puerta, J.A.; Gedmintas, L.; Costenbader, K.H. The association between silica exposure and development of ANCA-associated vasculitis: Systematic review and meta-analysis. Autoimmun. Rev. 2013, 12, 1129–1135.
• 130.
  Benedek, T.G.; Zawadzki, Z.A.; Medsger, T.A., Jr. Serum immunoglobulins, rheumatoid factor, and pneumoconiosis in coal miners with rheumatoid arthritis. Arthritis Rheum. 1976, 19, 731–736.
• 131.
  Archer, C.; Gordon, D.A. Silica and progressive systemic sclerosis (scleroderma): Evidence for workers’ compensation policy. Am. J. Ind. Med. 1996, 29, 533–538.
• 132.
  Baur, X.; Heger, M.; Bohle, R.M.; et al. Guideline (S2k, AWMF) of the Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin and the Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin “Diagnostics and Expert Opinion in the Occupational Disease No. 4101 Silicosis (Including Coal Worker’s Pneumoconiosis)”. Pneumologie 2016, 70, 782–812. (In German).
• 133.
  The Industrial Injuries Advisory Council Position Paper. Occupational Exposure to Crystalline Silica and Its Relation to Connective Tissue Diseases. Available online: https: Assets.publishing.service.gov.uk/media/5b278dcae5274a190f3b9cf3/occupational-exposure-to-crystalline-silica-and-its-relation-to-connective-tissue-diseases-iiac-position-paper-42.pdf (accessed on 14 March 2025).
• 134.
  Schmid, M.; Grolimund Berset, D.; Krief, P.; et al. Should systemic sclerosis be recognised as an occupational disease in Switzerland? Swiss Med. Wkly. 2020, 150, w20193.
• 135.
  Council of the European Union; European Parliament. Directive (EU) 2017/2398 of the European Parliament and of the Council of 12 December 2017 amending Directive 2004/37/EC on the protection of workers from the risks related to the exposure to carcinogens or mutagens at work. Off. J. Eur. Union 2017.
• 136.
  US Department of Labor, Occupational Health and Safety Administration. Occupational Exposure to Respirable Crystalline Silica. Fed. Regist. 2016, 81, 16286–16288.